Zobrazeno 1 - 10
of 622
pro vyhledávání: '"E. Odenwald"'
Autor:
W.-D. Ludwig, A. Reiter, E. Odenwald, Martin Zimmermann, Helmut Gadner, Hansjörg Riehm, Günter Henze, Martin Schrappe, Jochen Harbott
Publikováno v:
Leukemia. 14:2205-2222
Four thousand, four hundred and forty eligible children of up to 18 years of age were treated in four consecutive trials between 1981 and 1995 with the treatment protocols of the Berlin-Frankfurt-Munster (BFM) study group for childhood acute lymphobl
Autor:
M. Lauten, Anja Möricke, Rita Beier, Martin Zimmermann, E. Odenwald, Andishe Attarbaschi, Martin Schrappe, Martin Stanulla, Felix Niggli
BACKGROUND: In the ALL-BFM studies for treatment of acute lymphoblastic leukemia, reduction of leukemic blasts in peripheral blood after a one-week prednisone pre-phase - the so-called prednisone response - has been used for risk stratification since
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8cc590e15df261351dd531bd867244
https://www.zora.uzh.ch/id/eprint/84396/
https://www.zora.uzh.ch/id/eprint/84396/
Autor:
Melchior Lauten, Charlotte M. Niemeyer, E. Odenwald, Andishe Attarbaschi, Martin Zimmermann, Barbara Meissner, Rita Beier, Martin Stanulla, Felix Niggli, Hansjörg Riehm, Martin Schrappe, Anja Möricke
Publikováno v:
Haematologica. 97(7)
BACKGROUND: In the ALL-BFM 95 trial for treatment of acute lymphoblastic leukemia, response to a prednisone pre-phase (prednisone response) was used for risk stratification in combination with age and white blood cell count at diagnosis, response to
Autor:
W.-D. Ludwig, Dietrich Henzler, E. Odenwald, H.-H. Wacker, Reza Parwaresch, M. Tiemann, H. Riehm, Elif Yakisan, Alfred Reiter, Martin Schrappe, Karl-Walter Sykora, A. Brandt
Publikováno v:
Klinische Pädiatrie. 206:222-233
One of the goals of the study NHL-BFM 90 was to investigate the distribution and prognosis of the different subtypes of Non-Hodgkin's Lymphoma (NHL) in children and adolescents according to histological, cytomorphological and immunological characteri
Autor:
M. Schrappe, A. Reiter, S. Sauter, W. Ludwig, B. Wörmann, J. Harbott, C. Bender-Götze, W. Dörffel, R. Dopfer, E. Frey, W. Havers, G. Henze, J. Kühl, R. Richter, J. Ritter, J. Treuner, F. Zintl, E. Odenwald, K. Welte, H. Riehm
Publikováno v:
Klinische Pädiatrie. 206:208-221
In the ongoing trial ALL-BFM 90 for the treatment of childhood non-B cell acute lymphoblastic leukemia (ALL) 1468 unselected patients (pts) were enrolled from 84 centers in Germany and Switzerland from 4/90 to 12/93. Based on the results of the previ
Autor:
Ding, Shun1 (AUTHOR), Chen, Jiao2 (AUTHOR), Su, Jiajun1 (AUTHOR), Liu, Jiewen1 (AUTHOR), Yin, Weihua3 (AUTHOR), Qi, Fengjie1 (AUTHOR) qifj2005@163.com
Publikováno v:
Diagnostic Pathology. 8/16/2024, Vol. 19 Issue 1, p1-7. 7p.
Autor:
Georg Mann, Charlotte M. Niemeyer, E. Odenwald, T. Klingebiel, Dietrich Niethammer, Bernhard Kremens, Helmut Gadner, J. Ritter, Hansjörg Riehm, Felix Zintl, W.-D. Ludwig, Martin Stanulla, Felix Niggli, Jochen Harbott, A. Reiter, André Schrauder, Martin Schrappe, Karl Welte, M Zimmermann, Günter Henze, Anja Möricke
Between 1981 and 2000, 6609 children (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406563b142cef3d5360a4182b133dcf7
https://www.ncbi.nlm.nih.gov/pubmed/20010625
https://www.ncbi.nlm.nih.gov/pubmed/20010625
Autor:
E. Odenwald, C Sperling, J V Teichmann, W.-D. Ludwig, H. Riehm, A. Reiter, J. Ritter, B. Komischke, S Sauter
Publikováno v:
Klinische Pädiatrie. 202:243-252
In the therapy studies ALL-BFM 83 and 86, immunophenotyping of ALL by monoclonal antibodies was performed in a total of 1162 protocol patients (ALL-BFM 83 n = 578; ALL-BFM 86 n = 584). Both studies yielded similar results with respect to the incidenc
Autor:
Wolfgang Müller, Alfred Reiter, Lawrence Souza, Cornelia Zeidler, E. Odenwald, Karl Welte, Hansjörg Riehm
Publikováno v:
Blood. 75:1056-1063
Severe congenital neutropenia (SCN) is a disorder of myelopoiesis characterized by severe neutropenia secondary to a maturational arrest at the level of promyelocytes. We treated five patients with SCN with recombinant human granulocyte-macrophage co
Autor:
W.-D. Ludwig, H. Riehm, Martin Schrappe, E. Odenwald, Anja Möricke, Martin Zimmermann, Helmut Gadner, A. Reiter, Jochen Harbott
Publikováno v:
Klinische Padiatrie. 217(6)
Large progress has been made in the treatment of acute lymphoblastic leukemia (ALL) of childhood and adolescence over the past 30 years. Eighty percent of the patients can be cured, but clinical subgroups with a dismal outcome can still be identified